Recruiting A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798 Conditions Adnexal Diseases, Advance Solid Tumors, Biliary Cancers, +37 more Locations Sun Yat-sen University Cancer Center — Guangzhou, Guangdong, China View Trial Details
Completed Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers NCT03162510 Conditions Biliary Cancers, Biliary Tract Diseases, Biliary Tract Neoplasms, +10 more Locations Taiwan Cooperative Oncology Group, National Health Research Institutes — Taipei, Taiwan View Trial Details
